183 related articles for article (PubMed ID: 26290589)
1. Acute serum amyloid A is an endogenous TLR2 ligand that mediates inflammatory and angiogenic mechanisms.
Connolly M; Rooney PR; McGarry T; Maratha AX; McCormick J; Miggin SM; Veale DJ; Fearon U
Ann Rheum Dis; 2016 Jul; 75(7):1392-8. PubMed ID: 26290589
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 2 (TLR2) induces migration and invasive mechanisms in rheumatoid arthritis.
McGarry T; Veale DJ; Gao W; Orr C; Fearon U; Connolly M
Arthritis Res Ther; 2015 Jun; 17(1):153. PubMed ID: 26055925
[TBL] [Abstract][Full Text] [Related]
3. Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model.
Connolly M; Marrelli A; Blades M; McCormick J; Maderna P; Godson C; Mullan R; FitzGerald O; Bresnihan B; Pitzalis C; Veale DJ; Fearon U
J Immunol; 2010 Jun; 184(11):6427-37. PubMed ID: 20435930
[TBL] [Abstract][Full Text] [Related]
4. Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway.
Mullan RH; Bresnihan B; Golden-Mason L; Markham T; O'Hara R; FitzGerald O; Veale DJ; Fearon U
Arthritis Rheum; 2006 Jan; 54(1):105-14. PubMed ID: 16385502
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 2 induced angiogenesis and invasion is mediated through the Tie2 signalling pathway in rheumatoid arthritis.
Saber T; Veale DJ; Balogh E; McCormick J; NicAnUltaigh S; Connolly M; Fearon U
PLoS One; 2011; 6(8):e23540. PubMed ID: 21858161
[TBL] [Abstract][Full Text] [Related]
6. The role of TLR2/JNK/NF-κB pathway in amyloid β peptide-induced inflammatory response in mouse NG108-15 neural cells.
Lin W; Ding M; Xue J; Leng W
Int Immunopharmacol; 2013 Nov; 17(3):880-4. PubMed ID: 24126115
[TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A activates nuclear factor-kappaB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products.
Okamoto H; Katagiri Y; Kiire A; Momohara S; Kamatani N
J Rheumatol; 2008 May; 35(5):752-6. PubMed ID: 18322992
[TBL] [Abstract][Full Text] [Related]
8. Notch-1 mediates endothelial cell activation and invasion in psoriasis.
Rooney P; Connolly M; Gao W; McCormick J; Biniecka M; Sullivan O; Kirby B; Sweeney C; Molloy E; Markham T; Fearon U; Veale DJ
Exp Dermatol; 2014 Feb; 23(2):113-8. PubMed ID: 24330353
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts.
Jung YO; Cho ML; Kang CM; Jhun JY; Park JS; Oh HJ; Min JK; Park SH; Kim HY
Immunol Lett; 2007 Mar; 109(1):21-7. PubMed ID: 17289161
[TBL] [Abstract][Full Text] [Related]
10. Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor-associated kinase 4 and nuclear factor-κB.
O'Reilly S; Cant R; Ciechomska M; Finnigan J; Oakley F; Hambleton S; van Laar JM
Immunology; 2014 Nov; 143(3):331-40. PubMed ID: 24476318
[TBL] [Abstract][Full Text] [Related]
11. Serum amyloid A stimulates cultured endothelial cells to migrate and proliferate: inhibition by the multikinase inhibitor BIBF1120.
Cai X; Freedman SB; Witting PK
Clin Exp Pharmacol Physiol; 2013 Sep; 40(9):662-70. PubMed ID: 23819722
[TBL] [Abstract][Full Text] [Related]
12. TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.
Quero L; Hanser E; Manigold T; Tiaden AN; Kyburz D
Arthritis Res Ther; 2017 Nov; 19(1):245. PubMed ID: 29096690
[TBL] [Abstract][Full Text] [Related]
13. Serum Amyloid A Induces Toll-Like Receptor 2-Dependent Inflammatory Cytokine Expression and Atrophy in C2C12 Skeletal Muscle Myotubes.
Passey SL; Bozinovski S; Vlahos R; Anderson GP; Hansen MJ
PLoS One; 2016; 11(1):e0146882. PubMed ID: 26784349
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
[TBL] [Abstract][Full Text] [Related]
15. Dysfunctional high-density lipoprotein activates toll-like receptors via serum amyloid A in vascular smooth muscle cells.
Schuchardt M; Prüfer N; Tu Y; Herrmann J; Hu XP; Chebli S; Dahlke K; Zidek W; van der Giet M; Tölle M
Sci Rep; 2019 Mar; 9(1):3421. PubMed ID: 30833653
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-37 suppresses ICAM-1 expression in parallel with NF-κB down-regulation following TLR2 activation of human coronary artery endothelial cells.
Xie Y; Li Y; Cai X; Wang X; Li J
Int Immunopharmacol; 2016 Sep; 38():26-30. PubMed ID: 27233003
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A.
Cheng N; He R; Tian J; Ye PP; Ye RD
J Immunol; 2008 Jul; 181(1):22-6. PubMed ID: 18566366
[TBL] [Abstract][Full Text] [Related]
18. A role for the high-density lipoprotein receptor SR-B1 in synovial inflammation via serum amyloid-A.
Mullan RH; McCormick J; Connolly M; Bresnihan B; Veale DJ; Fearon U
Am J Pathol; 2010 Apr; 176(4):1999-2008. PubMed ID: 20304957
[TBL] [Abstract][Full Text] [Related]
19. Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis.
Lee MS; Yoo SA; Cho CS; Suh PG; Kim WU; Ryu SH
J Immunol; 2006 Oct; 177(8):5585-94. PubMed ID: 17015746
[TBL] [Abstract][Full Text] [Related]
20. Serum amyloid A receptor blockade and incorporation into high-density lipoprotein modulates its pro-inflammatory and pro-thrombotic activities on vascular endothelial cells.
Chami B; Barrie N; Cai X; Wang X; Paul M; Morton-Chandra R; Sharland A; Dennis JM; Freedman SB; Witting PK
Int J Mol Sci; 2015 May; 16(5):11101-24. PubMed ID: 25988387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
